Medigen Vaccine Biologics Corporation (TPEX:6547)

Medigen Vaccine Biologics Statistics

Total Valuation

TPEX:6547 has a market cap or net worth of TWD 12.49 billion. The enterprise value is 11.09 billion.

Market Cap	12.49B
Enterprise Value	11.09B

Important Dates

The next estimated earnings date is Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:6547 has 328.75 million shares outstanding. The number of shares has decreased by -1.44% in one year.

Current Share Class	328.75M
Shares Outstanding	328.75M
Shares Change (YoY)	-1.44%
Shares Change (QoQ)	+1.28%
Owned by Insiders (%)	0.29%
Owned by Institutions (%)	3.38%
Float	252.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	19.76
PB Ratio	3.41
P/TBV Ratio	3.43
P/FCF Ratio	n/a
P/OCF Ratio	336.47
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-78.37
EV / Sales	17.55
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3,082.91

Financial Position

The company has a current ratio of 13.70, with a Debt / Equity ratio of 0.08.

Current Ratio	13.70
Quick Ratio	10.50
Debt / Equity	0.08
Debt / EBITDA	45.98
Debt / FCF	-85.53
Interest Coverage	-15.02

Financial Efficiency

Return on equity (ROE) is -3.77% and return on invested capital (ROIC) is -2.03%.

Return on Equity (ROE)	-3.77%
Return on Assets (ROA)	-1.95%
Return on Invested Capital (ROIC)	-2.03%
Return on Capital Employed (ROCE)	-3.32%
Revenue Per Employee	6.14M
Profits Per Employee	-1.37M
Employee Count	103
Asset Turnover	0.15
Inventory Turnover	0.50

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.45% in the last 52 weeks. The beta is 1.01, so TPEX:6547's price volatility has been similar to the market average.

Beta (5Y)	1.01
52-Week Price Change	-18.45%
50-Day Moving Average	40.34
200-Day Moving Average	44.59
Relative Strength Index (RSI)	40.71
Average Volume (20 Days)	886,033

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6547 had revenue of TWD 632.12 million and -141.54 million in losses. Loss per share was -0.43.

Revenue	632.12M
Gross Profit	387.19M
Operating Income	-131.40M
Pretax Income	-141.54M
Net Income	-141.54M
EBITDA	-8.80M
EBIT	-131.40M
Loss Per Share	-0.43

Balance Sheet

The company has 1.71 billion in cash and 307.75 million in debt, giving a net cash position of 1.40 billion or 4.26 per share.

Cash & Cash Equivalents	1.71B
Total Debt	307.75M
Net Cash	1.40B
Net Cash Per Share	4.26
Equity (Book Value)	3.67B
Book Value Per Share	11.01
Working Capital	2.27B

Cash Flow

In the last 12 months, operating cash flow was 37.13 million and capital expenditures -40.73 million, giving a free cash flow of -3.60 million.

Operating Cash Flow	37.13M
Capital Expenditures	-40.73M
Free Cash Flow	-3.60M
FCF Per Share	-0.01

Margins

Gross margin is 61.25%, with operating and profit margins of -20.79% and -22.39%.

Gross Margin	61.25%
Operating Margin	-20.79%
Pretax Margin	-22.39%
Profit Margin	-22.39%
EBITDA Margin	-1.39%
EBIT Margin	-20.79%
FCF Margin	n/a

Dividends & Yields

TPEX:6547 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.44%
Shareholder Yield	n/a
Earnings Yield	-1.13%
FCF Yield	-0.03%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 3, 2022. It was a forward split with a ratio of 1.48280574.

Last Split Date	Aug 3, 2022
Split Type	Forward
Split Ratio	1.48280574

Scores

Altman Z-Score	n/a
Piotroski F-Score	4